Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Response Biomed Corp RPBIF

"Response Biomedical Corp is engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets."


GREY:RPBIF - Post by User

Post by dimar66on May 14, 2013 5:36pm
310 Views
Post# 21391704

We are not sitting still.

We are not sitting still.I can see how the Chinese distributors would be less than enthusiastic about the fact that RBM is opening their own distribution centre in China and taking control of the regulatory certification, and trim their margins. They probably aren't as interested in promoting the product right now. This strategy should work better for RBM in the long run. I suppose things will look better for Q3 and Q4 while Q2 looks to me to be at best flat.Here is an interesting link to some statistics about who owns RBMhttps://apps.cnbc.com/view.asp?country=US&uid=stocks/ownership&symbol=rbm-T&country=CAI believe management are taking the best coarse in these matters, although it again takes more time until good results come out. Things have improved considerably over the last year, so we are not sitting still.>
<< Previous
Bullboard Posts
Next >>